Skip to main content
. 2022 Jul 10;58(7):918. doi: 10.3390/medicina58070918

Table 1.

Demographical, ocular, and biochemical characteristics in the study groups.

Parameters Group 1 (n = 21) Group 2 (n = 20) Group 3 (n = 22) p 1
Age (years) 71.14 ± 9.69 71.75 ± 9.03 63.41 ± 5.84 0.002 *
Sex (n, male: female) 9:12 8:12 9:13 0.982 ^
BCVA (logMAR) 0.26 ± 0.23 0.14 ± 0.15 0.27 ± 0.22 0.056 ˘
SE (D) 0.26 ± 1.50 0.08 ± 1.18 0.16 ± 1.54 0.907 ˘
IOP (mmHg) 13.90 ± 3.41 14.70 ± 1.75 16.86 ± 2.23 0.001 *
Lens status (n, phakic: pseudophakic) 10:11 9:11 20:2 0.002 ^
Axial length (mm) 22.78 ± 0.74 22.76 ± 0.61 22.87 ± 0.72 0.879 *
Fasting blood sugar (mmol/l) 5.63 ± 0.54 6.70 ± 1.02 9.67 ± 4.03 0.001 ˘
HbA1c (%) 5.64 ± 0.45 7.38 ± 2.88 7.96 ± 1.78 0.001 ˘
Diabetes duration (years) N/A 7.30 ± 2.69 9.59 ± 6.85 1 ×
DM treatment (n, OADs: OADs + insulin) N/A 19:1 13:9 0.01
HBP (n, %) 17 (80.95) 17 (85) 18 (77.27) 1

1 significance of differences between groups; N/A: non applicable * one-way ANOVA test; ^ Pearson Chi-square test; ˘ Kruskal–Wallis test; × Mann–Whitney U test; Fisher exact test; BCVA: best corrected visual acuity; logMAR: logarithm of the minimum angle of resolution; SE: spherical equivalent; D: diopters; IOP: intraocular pressure; HbA1c: glycated hemoglobin; OADs: oral antidiabetic drugs; DM: diabetes mellitus; HBP: high blood pressure.